EMA recommends withdrawal of marketing authorisations for levamisole medicinesE
Continue reading...

EMA recommends withdrawal of marketing authorisations for levamisole medicines
EMA recommends withdrawal of marketing authorisations for levamisole medicines
EMA’s safety committee (PRAC) recommended that medicines containing levamisole be withdrawn from the EU market. This...




